The COVAX Global Supply Forecast has announced that Ghana will receive a total of 2,412,000 doses of the COVID 19 vaccines by the first and second quarters of this year.
Ghana will get the AstraZeneca/Oxford vaccine, licensed to Serum Institute of India (SII) – also known as the “AZ/SII” type of vaccine.
In total, 240 million doses of the vaccine will be distributed to countries across the world to help fight the pandemic.
Globally, total doses are expected to cover, on average, 3.3% of the total population of the 145 countries receiving doses from at least one manufacturer.
This is in line with the COVAX Facility target to reach at least 3% population coverage in all countries in the first half of the year, enough to protect the most vulnerable groups such as health care workers.
The vaccines are AstraZeneca/Oxford vaccine, licensed to Serum Institute of India (SII) – known as “AZ/SII”, AstraZeneca/Oxford vaccine, under the advance purchase agreement between Gavi, the Vaccine Alliance and AstraZeneca – also known as “AZ”, as well as the Pfizer-BioNTech vaccine – also known as “Pfizer-BioNTech”.
President Akufo-Addo assures of vaccine delivery
In his last address to the nation on the fight against COVID-19, President Akufo-Addo assured that Ghana will take delivery of the first batch of the COVID 19 vaccines in March 2021.
The second batch of the vaccines is expected by June 2021.
Meanwhile, Ghana has recorded 777 new cases of COVID-19 bringing the country’s active case count to 5,786.
Sadly, the country has also recorded nine new deaths, pushing the death toll to 433.
The figures were published by the Ghana Health Service’s COVID-19 dashboard on Thursday, February 4, 2021.
So far, the country has recorded 68,559 confirmed cases of COVID 19 while 62,340 have recovered.
